-
Policy Critique: Ueda et al. On Japan’s COVID-19 Vaccine Public Health Response
Editorial This issue features the third entry in a growing category of peer-reviewed scholarship in Science, Public Health Policy & the…
-
Interest Rates Rise Again as Treasury Auction Comes Up Short
On Wednesday, the Treasury bonds auction was so weak that 20-year and…
-
Part 2: Why RFK Jr.’s Call for Placebo-Controlled Vaccine Trials Is Justified — And Worth Expanding
By Torsten Engelbrecht, Marvin Haberland Editor’s note: This article is Part 2…
-
Mourning on Schedule: How Grieving Became a ‘Mental Illness’
I wrote this poem five months after Ginny’s passing: Waking Up…
Editor’s Choice
About the Journal
This initiative exists to help insure that policies in public health practice and law are founded on a full consideration of available knowledge derived by robust science. From Dr Lyons-Weiler: “While IPAK will continue to conduct basic, clinical and translational biomedical research in a completely unbiased manner, and will pubish results regardless of the outcome, it will also be increasingly centered on questions of policy and law that impact public health, laws that impact public health, and cases and rulings that impact the citizen’s expression of self-governance through law. We’re putting the Public back into Public Health.”